Nutrition 21 Growth Strategy: Increased Retail Presence, R&D Focus
This article was originally published in The Tan Sheet
Executive Summary
Nutrition 21 plans to increase its efforts in both the retail and R&D sides of its business to combat losses in the first two quarters of FY 2002
You may also be interested in...
Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives
Nutrition 21 plans to support the broad launch of its Diachrome chromium picolinate/biotin blend with a relatively large-scale clinical study, according to President and CEO Gail Montgomery
Nutrition 21 Lite Bites Bars Reaching Club Stores In The New Year
Nutrition 21's Lite Bites nutrition bars will make their retail debut in Sam's Club and Costco club stores in January under an exclusive marketing agreement with Leiner Health Products announced Oct. 31
Nutrition 21
Obtains exclusive patent rights for use of chromium to relieve symptoms of depression and premenstrual syndrome (U.S. Patent Nos. 6,034,125 and 5,972,390, respectively) when administered at doses ranging from 200 mcg to 500 mcg, Chromax manufacturer announces May 24. Ingredient supplier also is sponsoring upcoming study at Duke University Medical Center, led by Professor of Psychiatry Jonathan Davidson, MD, to further substantiate chromium picolinate's beneficial effects on depression